Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2009-09-18

Clinical Trial Update: Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intravenous magnesium sulfate versus oral nifedipine for tocolysis in a fetal fibronectin–positive preterm labor population was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (IV) (magnesium sulfate)
  • Nifedipine (oral) (nifedipine)

Snippet

Sponsor: MemorialCare | Conditions: Labor, Premature | Phase 3 | Status: TERMINATED